[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0802873D0 - Pharmaceutical dosage forms for delayed and extended release - Google Patents

Pharmaceutical dosage forms for delayed and extended release

Info

Publication number
GB0802873D0
GB0802873D0 GB0802873A GB0802873A GB0802873D0 GB 0802873 D0 GB0802873 D0 GB 0802873D0 GB 0802873 A GB0802873 A GB 0802873A GB 0802873 A GB0802873 A GB 0802873A GB 0802873 D0 GB0802873 D0 GB 0802873D0
Authority
GB
United Kingdom
Prior art keywords
delayed
dosage forms
pharmaceutical dosage
extended release
extended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0802873A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoqus Ltd
Original Assignee
Phoqus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoqus Ltd filed Critical Phoqus Ltd
Priority to GB0802873A priority Critical patent/GB0802873D0/en
Publication of GB0802873D0 publication Critical patent/GB0802873D0/en
Ceased legal-status Critical Current

Links

GB0802873A 2008-02-15 2008-02-15 Pharmaceutical dosage forms for delayed and extended release Ceased GB0802873D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0802873A GB0802873D0 (en) 2008-02-15 2008-02-15 Pharmaceutical dosage forms for delayed and extended release

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0802873A GB0802873D0 (en) 2008-02-15 2008-02-15 Pharmaceutical dosage forms for delayed and extended release

Publications (1)

Publication Number Publication Date
GB0802873D0 true GB0802873D0 (en) 2008-03-26

Family

ID=39271817

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0802873A Ceased GB0802873D0 (en) 2008-02-15 2008-02-15 Pharmaceutical dosage forms for delayed and extended release

Country Status (1)

Country Link
GB (1) GB0802873D0 (en)

Similar Documents

Publication Publication Date Title
HRP20160579T1 (en) Indole compound and pharmaceutical use thereof
AP2010005341A0 (en) Solid pharmaceutical dosage form
IL207128A0 (en) Pharmaceutical dosage form
ZA201102406B (en) Pharmaceutical composition for modified release
GB0803072D0 (en) Solid pharmaceutical and vaccien dose
HK1163539A1 (en) Solid pharmaceutical composition comprising amlodipine and losartan
IL207378A0 (en) Pharmaceutical solid state forms
EP2379079A4 (en) Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
HK1162936A1 (en) Solid pharmaceutical formulation with delayed release
IL204528A (en) Combined sustained and immediate release metadoxine pharmaceutical dosage forms
ZA201104348B (en) Pharmaceutical preparation
ZA200903858B (en) Pharmaceutical dosage form
EP2251006A4 (en) Microparticles and pharmaceutical compositions thereof
EP2437733A4 (en) Sustained release dosage form
GB0815972D0 (en) Pharmaceutical preparation
IL219617A0 (en) Pharmaceutical solid dosage form
GB0719248D0 (en) Compounds and methods for pharmaceutical use
ZA201104710B (en) Pharmaceutical dispenser and use thereof
EP2322505A4 (en) 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same
GB0902648D0 (en) Pharmaceutical compounds and compositions
ZA201104564B (en) Low dosage controlled release tablet
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0802873D0 (en) Pharmaceutical dosage forms for delayed and extended release
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)